CorMedix (CRMD)
(Real Time Quote from BATS)
$6.20 USD
+0.13 (2.14%)
Updated Aug 30, 2024 12:04 PM ET
2-Buy of 5 2
F Value F Growth C Momentum F VGM
Earnings News For CRMD
-
CorMedix (CRMD) Reports Q2 Loss, Tops Revenue Estimates
-
CorMedix: Q2 Earnings Snapshot
-
CorMedix Inc. Reports Second Quarter and Six Month 2024 Financial Results and Provides Business Update
-
CorMedix: Q1 Earnings Snapshot
-
CorMedix Inc. Reports First Quarter 2024 Financial Results and Provides Business Update
-
CorMedix: Q4 Earnings Snapshot
-
CorMedix Inc. Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
-
CorMedix: Q3 Earnings Snapshot
-
CorMedix Inc. Reports Third Quarter and Nine Month 2023 Financial Results and Provides Business Update
-
CorMedix: Q2 Earnings Snapshot
-
CorMedix Inc. Reports Second Quarter and Six Month 2023 Financial Results and Provides Business Update
-
CorMedix: Q1 Earnings Snapshot
-
CorMedix Inc. Reports First Quarter 2023 Financial Results and Provides Business Update
-
CorMedix: Q4 Earnings Snapshot
-
CorMedix Inc. Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update
-
Cormedix Inc. to Report Fourth Quarter and Fiscal Year 2022 Financial Results and Provide a Corporate Update on March 30, 2023
-
CorMedix: Q3 Earnings Snapshot
-
CorMedix Inc. Reports Third Quarter 2022 Financial Results and Provides Business Update
-
CorMedix: Q2 Earnings Snapshot
-
CorMedix Inc. Reports Second Quarter and Six Month 2022 Financial Results and Provides Business Update
-
CorMedix (CRMD) Reports Q1 Loss, Lags Revenue Estimates
-
CorMedix (CRMD) Reports Q4 Loss, Tops Revenue Estimates
-
CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates
-
CorMedix (CRMD) May Report Negative Earnings: Know the Trend Ahead of Q3 Release
-
CorMedix (CRMD) Reports Q2 Loss, Lags Revenue Estimates